Ramucirumab (Hanya ta Jijiya)

Cyramza

Ana amfani da allurar Ramucirumab kaɗai ko tare da paclitaxel don magance ciwon daji na ciki ko na haɗin ciki da makogwaro (GEJ) wanda ya bazu ko ya yadu zuwa wasu sassan jiki bayan mai haƙuri ya karɓi wasu magungunan ciwon daji (misali, magunguna masu ɗauke da fluoropyrimidine ko platinum) amma bai yi aiki sosai ba. Ana kuma amfani da allurar Ramucirumab tare da erlotinib azaman maganin farko na ciwon daji na huhu wanda bai yi girma sosai ba (NSCLC) wanda ya yadu zuwa wasu sassan jiki ga marasa lafiya masu wasu nau'ikan kwayoyin halittar epidermal growth factor receptor (EGFR) (sharewar exon 19 ko canjin exon 21). Likitanka zai yi gwaji kafin ka ɗauki wannan magani. Ana kuma amfani da allurar Ramucirumab tare da docetaxel don magance ciwon daji na huhu wanda bai yi girma sosai ba (NSCLC) wanda ya yadu zuwa wasu sassan jiki ga marasa lafiya da suka karɓi wasu magungunan ciwon daji (misali, magunguna masu ɗauke da platinum). Ana ba da shi ga marasa lafiya waɗanda ke da ciwon daji na EGFR ko ALK kuma sun gwada magani don waɗannan ciwon daji amma bai yi aiki sosai ba. Ana kuma amfani da allurar Ramucirumab tare da folinic acid, 5-fluorouracil, da irinotecan (FOLFIRI) don magance ciwon daji na hanji wanda ya yadu zuwa wasu sassan jiki (mCRC) ga marasa lafiya da suka karɓi wasu magungunan ciwon daji (misali, bevacizumab, oxaliplatin, ko magunguna masu ɗauke da fluoropyrimidine) amma bai yi aiki sosai ba. Ana kuma amfani da allurar Ramucirumab don magance nau'in ciwon daji na hanta da ake kira hepatocellular carcinoma (HCC) ga marasa lafiya da suka karɓi wasu magunguna (misali, sorafenib). Wannan magani ana ba shi ne kawai ta ko a ƙarƙashin kulawar likitanka kai tsaye. Wannan samfurin yana samuwa a cikin nau'ikan maganin da ke ƙasa:

A yayin yanke shawarar amfani da magani, dole ne a auna haɗarin shan maganin da amfanin da zai yi. Wannan shawara ce da kai da likitank za ku yi. Don wannan magani, ya kamata a yi la'akari da masu zuwa: Ka gaya wa likitank idan ka taɓa samun wata illa ta musamman ko rashin lafiyar jiki ga wannan magani ko wasu magunguna. Hakanan ka gaya wa ƙwararren kiwon lafiyarka idan kana da wasu nau'ikan rashin lafiyar jiki, kamar abinci, dyes, masu kiyayewa, ko dabbobi. Ga samfuran da ba tare da takardar sayarwa ba, karanta lakabin ko kayan abubuwan da ke cikin fakitin a hankali. An gudanar da nazarin da ya dace ba a kan dangantakar shekaru da tasirin allurar ramucirumab a cikin yaran da ke ƙarƙashin shekaru 18 ba. Ba a tabbatar da aminci da inganci ba. Nazarin da aka gudanar har yau bai nuna matsaloli na musamman ga tsofaffi da za su iyakance amfanin allurar ramucirumab ga tsofaffi ba. Babu bincike mai isasshen gaskiya ga mata don tantance haɗarin jariri lokacin amfani da wannan magani yayin shayarwa. Auna fa'idodin da za su iya samuwa da haɗarin da za su iya samuwa kafin shan wannan magani yayin shayarwa. Ko da yake ba za a iya amfani da wasu magunguna tare ba, a wasu lokuta ana iya amfani da magunguna daban-daban biyu tare ko da haɗuwa na iya faruwa. A waɗannan lokuta, likitank na iya son canza kashi, ko kuma wasu matakan kariya na iya zama dole. Ka gaya wa ƙwararren kiwon lafiyarka idan kana shan wasu magunguna ko na OTC (over-the-counter). Ba za a iya amfani da wasu magunguna a lokacin ko kusa da lokacin cin abinci ko cin wasu nau'ikan abinci ba saboda haɗuwa na iya faruwa. Amfani da barasa ko taba tare da wasu magunguna na iya haifar da haɗuwa. Tattauna da ƙwararren kiwon lafiyarka amfani da maganinka tare da abinci, barasa, ko taba. Kasancewar wasu matsalolin lafiya na iya shafar amfani da wannan magani. Tabbatar ka gaya wa likitank idan kana da wasu matsalolin lafiya, musamman: